Utility of interferon-gamma releasing assay for the diagnosis of active tuberculosis in children: A systematic review and meta-analysis.

ABSTRACT

INTRODUCTION: The accurate diagnosis of tuberculosis (TB) in children is essential for its effective management and control. Reliable diagnostic tools that are currently available for identifying TB infection include the in vivo tuberculosis skin test (TST) and ex vivo interferon-gamma release assays (IGRAs). This systematic review and meta-analysis aimed to evaluate the diagnostic accuracy of IGRAs in children. METHODS: Of the 768 screened studies, 47 met the eligibility criteria. Data from 9065 patients, including 1086 (12.0 %) with confirmed TB, were included in the analysis. The overall quality of the included studies, assessed using the Quality Assessment of Diagnostic Accuracy Studies-2 tool, was unclear. RESULTS: The calculated pooled sensitivity and specificity of IGRAs in children were 0.85 (95 % confidence interval [CI] 0.79-0.89) and 0.94 (95 % CI 0.88-0.97), respectively. Subpopulation analysis revealed that the sensitivities and specificities were as follows QuantiFERON tests 0.83 (95 % CI 0.74-0.89) and 0.93 (95 % CI 0.87-0.96), T-SPOT 0.87 (95 % CI 0.79-0.91) and 0.99 (95 % CI 0.85-1.00), IGRAs in children under 15 years 0.77 (95 % CI 0.43-0.94) and 0.96 (95 % CI 0.84-0.97), and IGRAs in children under 5 years 0.85 (95 % CI 0.52-0.97) and 0.94 (95 % CI 0.90-0.99), respectively. CONCLUSIONS: This study demonstrated that the sensitivity and specificity of the IGRAs in children were moderate and high, respectively. Therefore, the IGRAs may be useful for detecting TB infection in children. CLINICAL TRIAL REGISTRATION The review protocol was prospectively registered with the University Hospital Medical Information Network Clinical Trials Registry (UMIN000046737).